Venture Capital
After an ‘amazing year,’ SR One raises $600M to fuel more drug startups

Dive Brief:• SR One, the former venture arm of GSK, has raised its second fund since spinning out of the pharmaceutical company, announcing Monday a …
Dive Brief:• SR One, the former venture arm of GSK, has raised its second fund since spinning out of the pharmaceutical company, announcing Monday a …